Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

4.225 -0.095 (-2.20%)

Streaming Delayed Price Updated: 1:50 PM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	285,656
Open	4.290
Bid (Size)	4.220 (100)
Ask (Size)	4.230 (600)
Prev. Close	4.320
Today's Range	4.145 - 4.320
52wk Range	1.290 - 5.080
Shares Outstanding	61,107,288
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited. ↗

August 18, 2026

The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.

Via The Motley Fool

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

August 11, 2026

From MacroGenics, Inc.

Via GlobeNewswire

Performance

YTD	+162.4%	+162.4%
1 Month	+10.6%	+10.6%
3 Month	+0.6%	+0.6%
6 Month	+103.1%	+103.1%
1 Year	+142.8%	+142.8%

More News

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

July 23, 2026

From MacroGenics, Inc.

Via GlobeNewswire

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

July 02, 2026

Via MediaOutReach

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals

July 02, 2026

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

June 22, 2026

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates ↗

May 27, 2026

Via MarketBeat

MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum

May 14, 2026

From MacroGenics, Inc.

Via GlobeNewswire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 12, 2026

Via Chartmill

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals

May 11, 2026

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

May 04, 2026

From MacroGenics, Inc.

Via GlobeNewswire

MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗

March 10, 2026

Via Stocktwits

Which stocks are moving on Tuesday? ↗

March 10, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

March 10, 2026

Via Chartmill

MacroGenics to Participate in Upcoming Investor Conferences

February 26, 2026

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

February 23, 2026

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

November 25, 2025

From MacroGenics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

November 06, 2025

From MacroGenics, Inc.

Via GlobeNewswire

What's going on in today's after hours session ↗

September 16, 2025

Via Chartmill

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

September 02, 2025

From MacroGenics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 21, 2025

Via Benzinga

Thursday's after hours session: top gainers and losers ↗

August 21, 2025

Via Chartmill

MacroGenics Revenue Doubles in Q2 ↗

August 14, 2025

Via The Motley Fool

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

August 13, 2025

From MacroGenics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is MacroGenics, Inc. - Common Stock publicly traded?

Yes, MacroGenics, Inc. - Common Stock is publicly traded.

What exchange does MacroGenics, Inc. - Common Stock trade on?

MacroGenics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for MacroGenics, Inc. - Common Stock?

The ticker symbol for MacroGenics, Inc. - Common Stock is MGNX on the Nasdaq Stock Market

What is the current price of MacroGenics, Inc. - Common Stock?

The current price of MacroGenics, Inc. - Common Stock is 4.225

When was MacroGenics, Inc. - Common Stock last traded?

The last trade of MacroGenics, Inc. - Common Stock was at 09/03/26 01:50 PM ET

What is the market capitalization of MacroGenics, Inc. - Common Stock?

The market capitalization of MacroGenics, Inc. - Common Stock is 258.18M

How many shares of MacroGenics, Inc. - Common Stock are outstanding?

MacroGenics, Inc. - Common Stock has 258M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.